Overall 5-year and 10-year survival was 38% and 29%, respectively. Patients who received intravesical chemotherapy (mitomycin C, doxorubicin or pirarubicin), whether immediately after surgery or ...

Intravesical instillation with live ... new insight into the clinical efficacy of BCG versus chemotherapy with mitomycin C in intermediate-risk and high-risk bladder cancer.

Data from the phase 3 ENVISION trial demonstrate the potential of UGN-102 as an effective and durable nonsurgical treatment ...

A medicine solution is then instilled into the bladder. Electrode pads are placed on the person's skin. The cutaneous and intravesical electrodes are then connected to a generator, which generates an ...

107822353 NMIBC stage – After the initial TURBT some patients need an immediate intravesical mitomycin therapy, and later as per risk stratification, patients would be further given either ...

These weekly treatments involve instilling either further Mitomycin C or a TB vaccine called BCG into the bladder via a small catheter. This is called intravesical treatments and fortunately they ...

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will particip ...